The U.S. Food and Drug Administration (FDA) has agreed to review an application seeking approval of AVT05, a proposed biosimilar for Simponi (golimumab), which is an approved treatment for ankylosing spondylitis. Developers Alvotech and Teva Pharmaceuticals said this marks the first time that the FDA has…
Read more
One evening in December, I scrolled through photos on my phone, looking back at each moment in time. As I swiped through the pictures, however, I found myself grimacing at a number of them and the experiences I was going through at the time: my selfie at the cafe downstairs;…
Ankylosing spondylitis (AS) is a type of arthritis that mainly affects the joints of the spine. Inflammation of the spaces between the vertebrae causes back pain and stiffness.
There is no single specific test to diagnose AS, and many of the symptoms (such as back pain) also can be caused by other conditions. A diagnosis often involves checking for common hallmarks of AS.
Patients’ symptoms usually progress gradually over time. They may be erratic because the type and severity of the symptoms can improve, worsen, or completely stop for periods of time.
Get regular updates to your inbox.
